Shares of Quest Diagnostics ( DGX -0.02%) rose more than 8% last week after the medical testing leader boosted its full-year sales and profit forecast. Quest's revenue jumped 10% year over year to $3 ...

Quest Diagnostics is back in focus after analysts lifted Fair Value estimates from US$223.44 to US$239.38, a move that has coincided with price targets shifting into the US$245 to US$265 range for ...

Quest Diagnostics, the world’s leading provider of diagnostic information services, said demand for COVID-19 tests “continues ...

July 23 (Reuters) - Quest Diagnostics on Thursday raised its full-year profit forecast, after demand for routine diagnostic ...

Quest Diagnostics (NYSE:DGX) reported double-digit revenue growth and raised its full-year 2026 outlook after what executives ...

A strong stock as of late has been Quest Diagnostics (DGX). Shares have been marching higher, with the stock up 10.5% over ...

Quest Diagnostics raised its full-year outlook after profit and sales rose in the second quarter. The diagnostic testing company on Thursday posted a profit of $320 million, or $2.84 a share, in the ...

Quest Diagnostics shows Q2 earnings beat, upgraded FY guidance, and continued market momentum. Check out why DGX stock is a ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

Quest Diagnostics (NYSE:DGX) reported second-quarter financial results on Thursday. The transcript from the company's ...

The stock's fall snapped a two-day winning streak.